Last updated: September 14, 2023
Sponsor: Sohag University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neurologic Disorders
Treatment
Pure tone audiometry PTA ,Speech audiometry ,Otoacoustic emission,Auditory evoked potentials including (ABR).
Clinical Study ID
NCT06041360
Soh-Med-23-07-08MS
Ages 12-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ranges from 12 to 50 years old.
- Disproportionate speech recognition score (SRS) with the hearing threshold level.
- The auditory brainstem response (ABR) test with no waveform or, disturbed waves or,detectable wave V at high intense stimulus.
- The otoacoustic emission (OAE) and/or cochlear microphonic (CM) potential may bepresent.
Exclusion
Exclusion Criteria:
- While the participants who have these criteria will be excluded from the study:
- Consistent SRS and ABR response with hearing threshold level.
- Abnormal finding in brain imaging.
- Patients with history of diabetes and/or other causes of peripheral neuropathy
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Pure tone audiometry PTA ,Speech audiometry ,Otoacoustic emission,Auditory evoked potentials including (ABR).
Phase:
Study Start date:
August 01, 2023
Estimated Completion Date:
August 01, 2024
Connect with a study center
Sohag university Hospital
Sohag,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.